Rankings
▼
Calendar
KMDA FY 2024 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$520M
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$161M
+12.9% YoY
Gross Profit
$70M
43.5% margin
Operating Income
$20M
12.5% margin
Net Income
$14M
9.0% margin
EPS (Diluted)
$0.25
Cash Flow
Operating Cash Flow
$48M
Free Cash Flow
$37M
Stock-Based Comp.
$874,000
Balance Sheet
Total Assets
$372M
Total Liabilities
$113M
Stockholders' Equity
$259M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$161M
$143M
+12.9%
Gross Profit
$70M
$55M
+26.1%
Operating Income
$20M
$10M
+99.2%
Net Income
$14M
$8M
+74.6%
← Q4 2023
All Quarters
Q1 2024 →